Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1715  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission

This article has been cited by
1Effects of Moxonidine Administration on Serum Neuropeptide Y Levels in Hypertensive Individuals: A Prospective Observational Study
Eleni Karlafti,Triantafyllos Didangelos,Emmanouil Benioudakis,Evangelia Kotzakioulafi,Georgia Kaiafa,Vasileios Kotsis,Antonios Ziakas,Michail Doumas,Antonios Goulas,Christos Savopoulos
2Effective strategies for prevention of cardiovascular complications in elderly patients with arterial hypertension and obesity (clinical example)
A. P. Pereverzev,O. D. Ostroumova,E. V. Mironova
Medical alphabet.2020;3(21)10
3Investigation of the vasorelaxant effects of moxonidine and its relaxation mechanism on the human radial artery when used as a coronary bypass graft
Bulent Sarac,Ozge Korkmaz,Ahmet Altun,Ihsan Bagcivan,Sabahattin Göksel,Sahin Yildirim,Ocal Berkan
Interactive CardioVascular and Thoracic Surgery.2015;21(3)342
4The Influence of Hypertensive Therapies on Circulating Factors: Clinical Implications for SCFAs, FGF21, TNFSF14 and TNF-a
Aaron L. Magno,Lakshini Y. Herat,Márcio G. Kiuchi,Markus P. Schlaich,Natalie C. Ward,Vance B. Matthews
Journal of Clinical Medicine.2020;9(9)2764
5Non-fixed combination perindopril+moxonidine for blood pressure control in hypertensive patients with metabolic syndrome
S.V. Nedogoda,E.V. Chumachek,A.A. Ledyaeva,V.V. Tsoma,D.S. Vlasov,O.I. Bychkova
Kardiologiya i serdechno-sosudistaya khirurgiya.2021;14(2)208
6Cardiovascular Effects Mediated by Imidazoline Drugs: An Update
Luis Cobos-Puc,Hilda Aguayo-Morales
Cardiovascular & Hematological Disorders-Drug Targets.2019;19(2)95
7DFT, molecular docking and experimental FT-IR, FT-Raman, NMR inquisitions on “4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine”: Alpha-2-imidazoline receptor agonist antihypertensive agent
S. Aayisha,T.S. Renuga Devi,S. Janani,S. Muthu,M. Raja,S. Sevvanthi
Journal of Molecular Structure.2019;1186(2)468
8Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review)
O. D. Ostroumova,I. A. Alyautdinova,S. N. Litvinova,A. V. Arablinskij,A. A. Kirichenko
Rational Pharmacotherapy in Cardiology.2021;17(1)124

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal